Skip to Content
Merck
CN
  • Simultaneous determination of cefepime and grepafloxacin in human urine by high-performance liquid chromatography.

Simultaneous determination of cefepime and grepafloxacin in human urine by high-performance liquid chromatography.

Journal of pharmaceutical and biomedical analysis (2004-09-08)
J A Ocaña González, F J Jiménez Palacios, M Callejón Mochón, F J Barragán de la Rosa
ABSTRACT

A liquid chromatographic method with UV detection for simultaneous determination of cefepime and grepafloxacin has been developed. The method uses a C18 column, equipped with a pre-column of the same material, and acetonitrile-0.1 M phosphoric acid/sodium hydroxide buffer (pH 3.0)-0.01 M n-octylamine (pH 3.0) as mobile phase in gradient mode. Mobile flow rate and sample volume injected were 1.3 mL min(-1) and 20 microL, respectively. Detection wavelengths were 259 nm for cefepime and 278 nm for grepafloxacin. The retention times were 4.03 min for cefepime and 8.85 min for grepafloxacin, with detection limits of 1.0 and 1.1 microg mL(-1), respectively. The method was applied to the determination of both antibiotics in spiked samples of human urine.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Octylamine, 99%
Sigma-Aldrich
Octylamine, ≥99.5%